Gliclazide and Injection site bruising - a phase IV clinical study of FDA data

Summary:

Injection site bruising is reported as a side effect among people who take Gliclazide (gliclazide), especially for people who are female, 60+ old, also take Metformin, and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people have Injection site bruising when taking Gliclazide. It is created by eHealthMe based on reports of 27,903 people who have side effects when taking Gliclazide from the FDA, and is updated regularly.

What is Gliclazide?

Gliclazide has active ingredients of gliclazide. It is often used in diabetes. eHealthMe is studying from 28,131 Gliclazide users. Check the latest studies of Gliclazide.

What is Injection site bruising?

Injection site bruising is found to be associated with 1,064 drugs and 1,051 conditions by eHealthMe. Check the latest studies of Injection site bruising.

On Jul, 07, 2026

27,903 people reported to have side effects when taking Gliclazide.
Among them, 61 people (0.22%) have Injection site bruising.

Could Gliclazide cause Injection site bruising?

Among these 61 people:

What is the gender of people who have Injection site bruising when taking Gliclazide? *

female: 88.52 %
male: 11.48 %

What is the age of people who have Injection site bruising when taking Gliclazide? *

What are other drugs people take besides Gliclazide? *

What are other side effects people have besides Injection site bruising? *

Diarrhea: 43 people, 70.49%
Injection Site Pain: 41 people, 67.21%
Pain In Extremity: 36 people, 59.02%
Fatigue (feeling of tiredness): 36 people, 59.02%
Pain: 35 people, 57.38%
High Blood Pressure: 33 people, 54.10%
Hypokinesia (decreased bodily movement): 28 people, 45.90%
Joint Pain: 28 people, 45.90%
Stress And Anxiety: 27 people, 44.26%
Blood Glucose Increased: 27 people, 44.26%

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 25 people, 40.98%
Psoriasis (immune-mediated disease that affects the skin): 8 people, 13.11%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 7 people, 11.48%
Anaemia (lack of blood): 7 people, 11.48%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 11.48%
Ovarian Cancer (cancer of ovary): 4 people, 6.56%
High Blood Pressure: 3 people, 4.92%
Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 3 people, 4.92%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 3.28%
Neuroendocrine Carcinoma Metastatic (cancer tumour that arise from cells of the endocrine (hormonal) and nervous systems and spreads to other part): 2 people, 3.28%

* Approximation only. Some reports may have incomplete information.

Do you take Gliclazide and have Injection site bruising?

- Check whether Injection site bruising is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gliclazide:

Gliclazide (28,131 reports)

Browse all side effects of Gliclazide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Injection site bruising:

Injection site bruising (1,064 drugs)

Browse all the conditions that are associated with Injection site bruising:

Injection site bruising (1,051 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gliclazide (the active ingredients of Gliclazide) and Gliclazide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.